See more : Weimob Inc. (WEMXF) Income Statement Analysis – Financial Results
Complete financial analysis of Canopy Growth Corporation (CGC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Canopy Growth Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- PGI Incorporated (PGAI) Income Statement Analysis – Financial Results
- Amano Corporation (6436.T) Income Statement Analysis – Financial Results
- Osaka Organic Chemical Industry Ltd. (4187.T) Income Statement Analysis – Financial Results
- Fittech Co.,Ltd (6706.TW) Income Statement Analysis – Financial Results
- N R Agarwal Industries Limited (NRAIL.NS) Income Statement Analysis – Financial Results
Canopy Growth Corporation (CGC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.canopygrowth.com
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 297.15M | 402.90M | 520.33M | 546.65M | 398.77M | 226.34M | 77.95M | 39.90M | 12.70M | 1.15M | 0.00 | 4.14K | 0.00 | 4.49K | 549.00 |
| Cost of Revenue | 216.26M | 507.04M | 713.38M | 479.69M | 430.46M | 137.41M | 3.76M | 2.26M | -6.29M | 731.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 80.88M | -104.14M | -193.05M | 66.96M | -31.68M | 88.93M | 74.19M | 37.63M | 18.99M | 414.35K | 0.00 | 4.14K | 0.00 | 4.49K | 549.00 |
| Gross Profit Ratio | 27.22% | -25.85% | -37.10% | 12.25% | -7.95% | 39.29% | 95.18% | 94.33% | 149.51% | 36.17% | 0.00% | 100.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 4.61M | 21.72M | 32.34M | 57.58M | 61.81M | 15.24M | 1.45M | 810.00K | 721.00K | 159.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 99.83M | 487.41M | 520.28M | 666.54M | 624.91M | 451.44M | 92.93M | 25.59M | 11.67M | 6.00M | 739.94K | 68.75K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 76.15M | 243.45M | 239.28M | 194.40M | 242.83M | 154.39M | 38.20M | 12.96M | 5.65M | 1.99M | 191.72K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 175.98M | 487.41M | 520.28M | 666.54M | 867.74M | 605.83M | 131.13M | 38.55M | 17.33M | 7.99M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
| Other Expenses | 129.01M | -21.72M | -32.34M | -57.58M | 63.62M | 21.51M | 20.49M | -585.00K | 2.26M | -966.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 309.60M | 487.41M | 520.28M | 666.54M | 993.17M | 642.58M | 153.07M | 45.43M | 20.30M | 8.15M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
| Cost & Expenses | 525.86M | 994.46M | 1.23B | 1.15B | 1.42B | 779.99M | 156.82M | 47.69M | 14.02M | 8.88M | 931.66K | 68.75K | 26.16K | 28.56K | 27.47K |
| Interest Income | 16.24M | 24.28M | 6.60M | 21.37M | 66.33M | 49.31M | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.76K | 4.49K | 549.00 |
| Interest Expense | 105.35M | 126.16M | 103.94M | 8.46M | 6.72M | 18.42M | 784.00K | 66.00K | 140.00K | 65.82K | 1.27K | 0.00 | 4.76K | 4.49K | 0.00 |
| Depreciation & Amortization | 53.18M | 80.03M | 114.42M | 127.12M | 125.01M | 46.92M | 20.49M | 6.06M | 2.26M | 362.90K | 4.19K | 0.00 | -4.76K | -4.49K | 0.00 |
| EBITDA | -312.83M | -2.88B | -121.15M | -1.50B | -1.31B | -631.83M | -29.80M | -692.00K | 938.00K | -6.96M | -925.99K | -64.61K | -26.16K | -24.07K | -26.92K |
| EBITDA Ratio | -105.28% | 434.27% | -44.12% | 31.36% | -340.35% | -213.54% | -118.58% | 17.12% | 20.27% | -618.02% | 0.00% | -1,559.07% | 0.00% | -536.27% | -4,903.10% |
| Operating Income | -228.71M | 1.67B | -1.08B | 44.30M | -1.67B | -553.65M | -78.88M | -15.22M | -2.75M | -7.74M | -931.66K | -64.61K | -21.39K | -19.58K | -26.92K |
| Operating Income Ratio | -76.97% | 413.30% | -208.08% | 8.10% | -418.53% | -244.61% | -101.19% | -38.14% | -21.65% | -675.34% | 0.00% | -1,559.07% | 0.00% | -436.27% | -4,903.10% |
| Total Other Income/Expenses | -242.64M | -455.64M | 750.94M | -440.51M | 159.91M | -59.71M | 68.53M | 3.81M | -621.00K | -912.37K | -1.27K | 0.00 | 0.00 | 0.00 | 26.92K |
| Income Before Tax | -471.36M | -3.31B | -329.43M | -1.68B | -1.51B | -657.78M | -52.54M | -17.06M | -3.37M | -8.93M | -932.93K | -64.61K | -21.39K | 0.00 | 0.00 |
| Income Before Tax Ratio | -158.63% | -822.61% | -63.31% | -308.05% | -378.43% | -290.61% | -67.41% | -42.76% | -26.54% | -779.58% | 0.00% | -1,559.07% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.33M | -4.77M | -8.95M | -13.14M | -121.61M | 12.32M | 1.59M | -401.00K | 126.00K | 1.42M | 2.75K | 0.00 | -4.76K | -4.49K | 26.92K |
| Net Income | -657.27M | -3.31B | -320.49M | -1.67B | -1.39B | -670.09M | -54.13M | -16.61M | -3.50M | -8.93M | -932.93K | -64.61K | -21.39K | -24.07K | -26.92K |
| Net Income Ratio | -221.19% | -821.42% | -61.59% | -305.65% | -347.93% | -296.06% | -69.45% | -41.63% | -27.53% | -779.58% | 0.00% | -1,559.07% | 0.00% | -536.27% | -4,903.10% |
| EPS | -6.47 | -71.37 | -8.19 | -44.96 | -39.86 | -1.99 | -0.31 | -0.14 | -0.05 | -0.30 | -15.77 | -0.06 | -0.02 | -0.02 | -0.08 |
| EPS Diluted | -8.79 | -71.37 | -8.19 | -44.96 | -39.86 | -1.99 | -0.31 | -0.14 | -0.05 | -0.30 | -15.77 | -0.06 | -0.02 | -0.02 | -0.08 |
| Weighted Avg Shares Out | 101.63M | 46.37M | 39.13M | 37.17M | 34.80M | 337.51M | 177.30M | 118.99M | 77.02M | 29.95M | 59.16K | 1.00M | 1.00M | 1.00M | 320.24K |
| Weighted Avg Shares Out (Dil) | 74.79M | 46.37M | 39.13M | 37.17M | 34.80M | 337.51M | 177.30M | 118.99M | 77.02M | 29.95M | 59.16K | 1.00M | 1.00M | 1.00M | 320.24K |
Canadian Gold Corp. Closes Over-Subscribed Private Placement
Toronto, Ontario--(Newsfile Corp. - July 17, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") announces the completion of its final tranche closing of its private placement offering, raising an aggregate $1,634,995 (see also news release dated June...
Top Canadian Cannabis Stocks to Watch in Mid-July 2024
The global cannabis industry and top marijuana stocks are booming, with a market value expected to reach $73.6 billion by 2027. This growth is driven by increasing legalization and consumer demand. Canadian cannabis stocks, in particular, are gaining attention due...
Canopy Growth Corporation (CGC) Advances But Underperforms Market: Key Facts
In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $6.50, denoting a +0.31% change from the preceding trading day.
The 7 Most Undervalued Meme Stocks to Buy in July 2024
Meme stocks looked to be on the comeback trail in May of this year after retail trader Keith Gill, known online as “Roaring Kitty,” made a triumphant return to social media after a three-year hiatus. By posting only a few...
It Has Been 5 Years Since Canopy Growth Made This Monumental Move
Canopy Growth parted ways with its CEO five years ago as it looked to improve its financial performance. The business has grown in five years, but it continues to struggle with profitability.
Hydrogen Utopia says medical cannabis business has landed Canopy Growth deal
Hydrogen Utopia International PLC (LSE:HUI, OTCQB:HUIPF) has flagged that Ohrid Organics, in which it is acquiring a 49% stake, has secured a supply agreement with Canopy Growth, one of the world's largest cannabis companies. Ohrid will produce five medicinal strains...
Will the U.S. Election Help Give Tilray Brands and Canopy Growth a Year-End Boost?
An election year means that talk of federal marijuana legalization is likely to ramp up in the months ahead. Multiple states, including Florida, could legalize recreational marijuana later this year.
7 Cannabis Stocks to Sell in July Before They Crash & Burn
Back in May, cannabis stocks briefly came back into vogue. This was due to a small amount of regulatory progress.
This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years
Curaleaf's Boris Jordan expects to see a lot of consolidation in the industry during the next decade. A lack of marijuana reform has made it difficult for cannabis companies to stay out of the red.
Canopy Growth Corporation (CGC) Surpasses Market Returns: Some Facts Worth Knowing
Canopy Growth Corporation (CGC) reachead $6.67 at the closing of the latest trading day, reflecting a +0.6% change compared to its last close.
Source: https://incomestatements.info
Category: Stock Reports